Garde Capital, Inc. Biogen Inc. Transaction History

Garde Capital, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $326,160 - $365,820	-1,500 Closed	0 $0
Q4 2018 Feb 20, 2019	SELL	$278.5 - $352.75 $13,646 - $17,284	-49 Reduced 3.16%	1,500 $451,000
Q1 2018 May 16, 2018	SELL	$260.13 - $367.91 $1,300 - $1,839	-5 Reduced 0.32%	1,549 $424,000
Q4 2017 Feb 23, 2018	SELL	$307.64 - $344.58 $6,152 - $6,891	-20 Reduced 1.27%	1,554 $495,000
Q3 2017 Nov 17, 2017	BUY	$281.15 - $329.69 $442,530 - $518,932	1,574	1,574 $493,000

1,018

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Garde Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Garde Capital, Inc. with notifications on news.